The pharmaceutical industry imports in Spain are forecasted to continue their growth trend from 2024 to 2028. In 2024, imports are valued at $42.29 billion, increasing significantly each year to $64.06 billion in 2028. Compared to the actual value in 2023, this represents a notable year-on-year increase. Specifically, from 2024 to 2025, there is an approximate 13% growth, with subsequent annual increases ranging from 11% to 15%. The compound annual growth rate (CAGR) over the five-year period is projected to be about 10.5%.
Future trends to watch for include:
- Continued advancements in pharmaceutical technology and innovation,- Policy changes impacting import regulations,- Shifts in global supply chain dynamics,- Market demand fluctuations driven by demographic changes. Monitoring these factors will be crucial for forecasting future market movements.
